GE Healthcare is launching OmnipaqueTM (iohexol) Oral Solution in the United States, a new, ready-to-drink contrast medium that can be used to help physicians diagnose medical conditions by improving the diagnostic visualization of the abdominal gastrointestinal tract.

Quantitative flow ratio (QFR) outperformed coronary angiography in calculating fractional flow reserve (FFR), a measurement key to determining heart blockages, according to a study in the Journal of the American Heart Association.

EchoNous, the Seattle-based medical tool provider, recently received FDA clearance for the its ultrasound-based tool designed for nurses to improve peripheral IV (PIV) catheter placements.

Myocardial delayed enhancement (MDE) CT rivaled late gadolinium enhanced (LGE) MRI in the detection and classification of myocardial scar in patients with heart failure, according to a recent Radiology study. The results may help identify features of chronic heart failure.

Patients with retrievable inferior vena cava (IVC) filters used to prevent venous thromboembolisms face increased complication risks the longer their device remains in the body. Researchers created an informatics tool to address the issue.

Jointly funded by the federal and Western Australia (WA) governments, a $21 million state-of-the-art MRI suite for patients seeking neurosurgery recently opened in Perth, Australia, according to a July 6 article in The Australian.

Patients with stable coronary artery disease (CAD) monitored with either cardiac MR (CMR) or angiography demonstrated no difference in impact rates over three years, according to a recent JACC: Cardiovascular Imaging study.

In those tested for coronary artery disease, research published July 3 in Radiology suggests that cardiac hybrid imaging with CT imaging and nuclear stress testing may be an effective predictor of heart attack risk and other adverse cardiac events.